My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
A subsidiary of Sun Pharmaceutical Industries has received approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of Sumatriptan Succinate Injection.
You are already a Moneycontrol Pro user.